Women’s lived experiences of learning to live with osteoporosis: a longitudinal qualitative study
© The Author(s). 2017
Received: 20 August 2016
Accepted: 7 March 2017
Published: 9 March 2017
A vast amount of literature exists concerning pharmaceutical adherence in osteoporosis. However, the process of learning to live with osteoporosis over time remains largely unknown. The purpose of this study was to gain a deeper understanding of the continued process of how women learn to live with osteoporosis. Our objective was to explore what characterizes women’s experiences of living with osteoporosis during the first year after diagnosis, when patients are prescribed anti-osteoporotic treatment, without having experienced an osteoporotic fracture.
Forty-two narrative qualitative interviews were conducted with fifteen recently diagnosed Danish women. A longitudinal design was chosen since this allows an investigation of the perspective over time. The interviews were conducted in the period of March 2011 to August 2012. Data were analyzed using a phenomenological-hermeneutic interpretation of text. No medical records were available for the researchers. All information with the exception of T-score was self-reported.
The participants’ experiences could be described in two key themes developed through the analysis: 1) “To become influenced by the medical treatment” which consisted of two sub-themes “taking the medication”, and “discontinuing the medication”. 2) “Daily life with osteoporosis”, which was characterized by three sub-themes: “interpretation of symptoms”, “interpretation of the scan results” and “lifestyle reflections”. The results highlighted that learning to live with osteoporosis is a multifaceted process that is highly influenced by the medical treatment. In some cases, this is a prolonged process that can take around one year.
The results suggest a need for improved support for individual women during the complex process of learning to live with osteoporosis. The study adds new knowledge that can be useful for healthcare professionals taking a health-oriented stance when supporting women in self-management of their illness. Further investigations of lived experiences over time in the field of osteoporosis research are therefore needed.
KeywordsChronic disease Denmark Lived experiences Longitudinal Medical treatment Newly-diagnosed Osteoporosis Phenomenological-hermeneutic Qualitative research Women
Osteoporosis is an increasing major public health problem [1–3] which affects hundreds of millions of people worldwide . This condition is, however, greatly underdiagnosed and undertreated [3–5], leading to an increased need for early detection, treatment and osteoporosis education to prevent deterioration and disability [4, 5], as well as the need to improve the prognosis , the quality of life [7–9] and to prevent premature death [3, 10, 11]. Osteoporosis is a chronic condition that is generally treatable in otherwise healthy individuals but it can also become severely debilitating if left untreated [2, 12].
Osteoporosis definition and causal explanations
“Severe osteoporosis (established osteoporosis). A bone mineral density (BMD) that is more than 2.5 standard deviation (SD) below the young adult mean in the presence of one or more fragility fractures” pp. 6 .
The diagnosis is made on the basis of a Dual-energy X-ray absorptiometry (DXA) scan and a quantitative assessment of the BMD, which is a determinant of bone strength. BMD is measured as a T-score in lumbar spine or hip. Low BMD can be a risk factor but does not always lead to fractures. The risk of fracture is highly influenced by other factors such as age, heredity, Body Mass Index, weight-bearing exercise and lifestyle [3, 15]. The most common physical consequences of osteoporosis are compression fractures of the spine, fracture at the hip, distal forearm and proximal humerus.
Epidemiology and fracture
The prevalence of female osteoporosis in the five largest countries in Europe (France, Germany, Italy, Spain and the UK) is high, with 21% of women aged 50–84 years (representing more than 12 million) being affected in these countries . In Denmark, there are no accurate figures of how many individuals are affected by osteoporosis, partly because the disease is often asymptomatic in the early stages and also because guidelines do not consider systematic screening initiatives to be justified [2, 16, 17]. However, Vestergaard et al. estimated in 1995 that 40.8% of women and 17.7% of men over 50 years of age have osteoporosis in Denmark . As a result of the increase in the size of the aging population [15, 18] along with an increased awareness of the condition, the number of men and women diagnosed as living with osteoporosis has also increased in recent decades.
Osteoporosis, consequences and challenges - a continued public health problem
The consequences of osteoporosis include physical, psychological, economic and societal factors [2, 10, 19]. It is a continued challenge to promote bone health and to prevent osteoporotic fractures [6, 7, 20] in a growing worldwide elderly population. This challenge is exacerbated by the fact that many individuals do not follow the prescribed anti-osteoporotic treatment as recommended [21–26]. Despite extensive investigations of this phenomenon, it seems that the underlying causal explanations of medication failure (such as quitting treatment early or low compliance to treatment leading to lack of treatment efficacy)  have not yet been fully explored. It has been suggested that the research in the field of fracture prevention treatment needs to focus on patients’ own perceptions [23, 27, 28]. This type of research calls for the use of qualitative research methods to make the voices of those involved heard.
A thorough understanding of women’s experience of osteoporosis
Studies have found that being diagnosed with osteoporosis may lead to psychological and physical consequences for the individuals, impacting their quality of life [8, 29–35]. In addition to this, patients may find it difficult to make sense of the diagnosis and its implications for their current and future health . These difficulties may be associated with the emotional challenges of handling the knowledge of the fracture risk , as well as thoughts about osteoporosis and risk perception influenced by stereotypes of bodily deterioration and founded on worst-case scenarios  and interpretations of information derived from the DXA scan as body fragility and risk . There are a variety of ways in which women with osteoporosis perceive themselves and manage their chronic illness and ageing, arguing that structural and psychological determinants of health behavior need to be understood in order to better understand and manage the disease [36, 37].
In the current study, we chose a qualitative method in order to supplement former studies of osteoporosis. This was chosen in order to explore the patient’s perspective of osteoporosis, and to detect areas where improvements in treatment could be made. The objective was to explore what characterizes women’s experiences of living with osteoporosis in the first year after diagnosis, when patients are prescribed anti-osteoporotic treatment, without experiencing an osteoporotic fracture.
This qualitative study used a phenomenological-hermeneutic approach of narratives and interpretation [38–40]. The French philosopher Paul Ricoeur’s work is commonly regarded as a bridge between the philosophies of phenomenology and hermeneutic . In this interpretation, the structures of subjective experience and consciousness, and the self and its realization are interpreted through the hermeneutic circle . The approach was chosen in order to be open towards patients’ perspectives when exploring women’s experiences, beliefs, attitudes, behavior and lifestyle when living with a new diagnosis of osteoporosis. Additionally, a longitudinal design was chosen because it allows the tracking of changes over time, and for examining development of patterns and changes. This may provide a more comprehensive level of information regarding individual experiences and perceptions .
The initial sampling of women 65 years or older who attended DXA scan took place at two hospitals in two different regions of Denmark. The methods of recruitment and discussion of non-participators have been reported elsewhere [44, 45]. In the present study, we investigated the experiences during the conversion to new life circumstances with osteoporosis.
Women were contacted when they attended a DXA scan at one of the two participating hospitals during the period of January to April 2011. Fifteen participants were included consecutively according to inclusion and exclusion criteria, the inclusion criteria being aged 65 years or older, with a new diagnosis of osteoporosis and a DXA scan showing a T-score below −2.5 (lower back or hip) , as well as no previous known osteoporotic fracture and self-reported confirmation of at least one of the known risk factors . In addition, all participants had been prescribed anti-osteoporotic pharmaceutical treatment. Exclusion criteria included signs of cognitive impairment, a previous diagnosis of osteoporosis, or previous treatment with anti-osteoporotic medication. The women who met the inclusion criteria were contacted by a healthcare professional, given an information letter and invited to participate in the study. Those who agreed to participate gave their name and phone number and were contacted shortly after by the researcher (CAH). One woman did not wish to continue participating when contacted prior to the second interview-round for personal reasons, and another was not reachable at the time of the last interview.
The participants gave three interviews, for a total of 42 interviews for analysis. The first interview took place shortly after diagnosis, the second interview about six months later and the third interview approximately one year after diagnosis. These points of time were chosen because studies have shown that patients’ medical adherence stabilizes around six months after initiation [46, 47] and adjustments to live with a chronic condition may be lengthy . An open approach was used to encourage the women to tell their individual stories of living with osteoporosis. An open interview guide (Additional file 1) was used . Preliminary, to etch interview the women were informed of the purpose of the study and informed consent was obtained. Initially, the women were asked an open-ended question: “Please tell me about your experiences of living with osteoporosis?” The researcher would then ask clarifying questions such as “Could you please elaborate what you were telling me about xx?” to capture the individual perspective . The interview guide was adjusted between interview-rounds . Interviews were performed between March 2011 and August 2012 until data saturation was reached; they were tape-recorded and subsequently transcribed verbatim. Field notes were taken immediately after each interview. No medical records were available for the researchers and none of the women were patients of the authors. All information with the exception of T-scores were self-reported.
The study was approved by the Danish Data Protection Agency (J.no. 2012-41-0875) and the National Committee on Health Research Ethics (J.no. H-C-FSP-2011_01), following the Helsinki Declaration . Informed written consent was obtained at the time of enrolment and oral consent before each interview.
Individual interviews were chosen in order to explore the individual perspective in depth. The role of the first author (CAH, while she remained Ph.D. student) as an interviewer may have affected the interviews because the participants knew that she was a nurse. The participants expressed expectations of getting the opportunity to get advice during the interview, however their questions were kindly circumvented until after the interview was completed. In accordance with ethical responsibilities’ and research principles, in most cases the women were encouraged to contact their GPs or other relevant healthcare professional for clarification of the questions, as well as in cases of any other health related problem which were considered needed to be examined by a physician. On the other hand, it is also possible that the participants were more open during the interviews due to the interviewer’s healthcare profession, or due to the interview performed in a private atmosphere in their home . However, the role as a nursing-researcher may have been diminished by conducting the interviews in the women’s homes, where the interaction was less affected by the interviewer’s professional status as she was a guest in the women’s homes.
Newly diagnosed patients’ are in a vulnerable situation and the experience of participation in a research study may possibly add an additional burden. When individuals have an opportunity to talk about their own experiences, they may gain meaning and understanding through telling their story which may be helpful when adapting to difficult situations . This may have been the case for several of the participating women, as they spontaneously described that they had chosen to participate in the project in order to have the opportunity to gain a better understanding of osteoporosis.
Throughout the data collection the participants’ needs were looked after through attentiveness to the individual needs and wishes in relation to interview time and location.
An example of the structural analysis and themes
what is said
what is spoken about
emissions of key themes
(1st interview round) ‘I am confused; I do not know what might harm. (…) I want to do preventive things as much as possible. (…)Does it takes ten years to develop a fracture or how fast? How unfortunate can I be? Will something suddenly break? Many people are having pain, that is turning around in my head after I have been told that I have osteoporosis’
being insecure when wanting to prevent uncertain consequences
Daily life with osteoporosis
The final interpretation is preceded by a critical analysis, continuing the dialectic process between explanation and comprehension as a discussion of relevant literature and other research findings relating to the interpretation level.
Baseline demographics of the included 15 women
Numbers of women
65–79 years (mean 71.9)
living with spouse
0–4 (2 women had no children)
chronic pulmonary lung disease
more than one comorbidity
BMI ≤ 19
smoking: any/alcohol (use): above the recommended 14 units per week
referral to DXA scan due to
general practitioner (GP)
own request to GP
follows the radio’s morning gymnastics program
the municipality’s gymnastics for the elderly, led by physiotherapist
always taking the stairs
more than one exercise form
An overview of key themes and sub themes
To become influenced by the medical treatment
- taking the medication
- discontinuing the medication
Daily life with osteoporosis
- interpretation of symptoms
- interpretation of scanning result
- lifestyle reflections
The themes will subsequently be described within the interpretation.
To become influenced by the medical treatment
Experiences of becoming influenced by the medical treatment were described in the first round of interviews, the main focus being on practical issues of how to take the prescribed medication and how to manage side effects. This focus on side effects continued through the second and third round of interviews and a need to seek information and advice was also described. This appeared to be a cognitive process, as reflected in decisions regarding whether to take or reject the medication. The key theme was described as a trajectory illuminated by two subthemes: “taking the medication” and “discontinuing the medication”.
Taking the medication
“The first time I took it I thought it was such an execution pill, probably a really strong one. I decided to take it Friday morning before the weekend. (…) I bought a green box and I dispensed for a week. On Fridays, I have attached a big red star. (…) The star tells me I cannot eat or drink anything before or lie down and all that” (5)
Osteoporosis is perceived as a condition that requires preventative action, as well as a disease to be taken seriously. Strategies for remembering to take the medication were described as being necessary.
“I take it Saturday morning when I get up. (…) I go for a walk, take a shower or walk back and forth. Then that hour has elapsed” (12)
“I get infusions. It's only once a year and it is in May. I've only got it twice so far. I feel no side effects or anything” (13)
Despite the general ease of the treatment, thoughts about side effects were prevalent in this case. This was mainly in the third round of interviews, one year after the diagnosis, where some degree of having obtained calm and coming to terms with the medical treatment emerged. This was in regard to both the perspective of deciding to take the medication as well as in light of convincing themselves that it is the best thing to do. In contrast, few women described the ease of treatment, which consisted of an immediate decision to follow the physician’s prescription without much reflection about this issue later on.
Discontinuing the medication
Discontinuing the medication appeared in the text as a process based on experiences during the first year after diagnosis. Three women either stopped or did not initiate recommended osteoporosis medication; all filled their prescription at least once.
“I did find an article.(…) There I read about making the dentist aware of it (…) It has something to do with the healing process of the jaw (…) If they [the tablets] are uncomfortable in some ways’ I am not sure (pause). I believe the medicine is a little harsh” (3)
“I felt weird in my stomach (…) I did not sleep well the first nights. (…) Maybe it's mental, but I really don't like taking them. I got the feeling that they were unpleasantly rough to my stomach. (…) Then I stopped taking them. I was wondering if they are so harsh, is it then worth taking them?” (15)
“I’ve got heart problems (…) it has overlapped with it [osteoporosis]. It is more important that the heart beats than I might have to sit in a wheelchair. I have chosen not to take the medication [anti-osteoporotic]. I am instead trying to do everything else to strengthen my bones” (3)
In this particular case, the experience of the decision was influenced by a larger life event of dealing with a potential heart failure.
“I'm not bothered by anything. I do not take those stupid pills. No I don't. I hate to take pills. The GP who gave them to me said that I might get side effects. I said ‘you know what? I do not want them it works just fine’. (…) On the other hand I am very (pause) I obey the doctor [she bought them anyway]” (11)
A pronounced reserved attitude towards taking medication was a general finding, although this example was the most distinct.
Daily life with osteoporosis
The theme “daily life with osteoporosis” was supported in the text by descriptions of a trajectory and evolution of experiences related to three subthemes: “interpretation of symptoms”; “interpretation of scanning result” and “lifestyle reflections” (Table 3).
Interpretation of symptoms
“It's [osteoporosis] apparently something that comes sneaking (…) I have not been able to understand why I got sore back again and again. I HAVE had back pain as if it explodes” (1)
“My GP has promised to help me find out about the pain I have. Whether it is associated with osteoporosis or whether it is something else. (…) He has to tell me what to do. (…) I have experienced that one can learn to live with pain. I am not just sitting in a chair” (10)
“I've been so ill, so I couldn't even pull the quilt up. Finally, I got it, ‘forsteo’. I have taken it for a year now. (…) The past one and a half months I sometimes wake up in the morning without having backache” (9)
This kind of reflection on symptoms emerged to be a common part of the cognitive process of accepting a future life with osteoporosis.
Interpretation of the DXA result
“Approximately three years ago I decided to get it [osteoporosis] examined, I was over the line, but far down [on the scale]. (…) In this fall I got it reassessed. (…) the numbers [from the DXA scan result] were almost the same but finally it was addressed (…) they said I have osteoporosis” (14)
“My sister was here recently. We compared her pictures with mine, and the values. (…) I don’t know when I am having the next scan. (…) I don’t know how fast you can see an effect [of the treatment on a DXA scan result]” (4)
“In December I’ll have to sign up for a new scan. Then we'll see if it shows any change. Some improvement hopefully (pause) or maybe there has been very little change” (2)
In addition, expectations regarding the next scanning result were found to be of value, since this was talked about as being the “proof” of whether the treatment was effective. As clarified by the quote, throughout the text future expectations were related to the hope of visual signs of improvement.
“I am confused; I do not know what might harm. (…) I want to do preventive things as much as possible. (…)Does it takes ten years to develop a fracture or how fast? How unfortunate can I be? Will something suddenly break? Many people are having pain. That is turning around in my head after I have been told that I have osteoporosis” (8)
“I have always been exercising, I have been eating healthily and I do not smoke and I do not drink. I think I have done what I could to have a healthy life. (…) I am always thinking whether I get enough calcium. At the pharmacy they say I have to take three tablets a day, otherwise I have been told that I have to take two a day, what am I supposed to do? (…) I am sort of pushing it in front of me all the time. Am I doing it right? Am I generating a hunched back or get a fracture? What will happen?” (15)
“I've known for many years that I probably had it [osteoporosis]. As a child I did not like milk. I had some allergies. (…) I still do not like milk therefore it is important to incorporate calcium in my food other than calcium tablets. I eat ten to twelve almonds every morning. (…) I eat sardines in oil and tuna in oil they are a little fat and have vitamin D” (7)
Part of the process of coming to terms to living with osteoporosis involved seeking an explanation to why the patients had developed osteoporosis. Most cases included reflections on “why”.
“We've a good life. He [the husband] is not able to talk. He has aphasia and a half-side paralysis. His mood is good. We have learned to live with that side of our lives, and that is more important than osteoporosis. (…) I do not know what to do about it, so I don't do anything. I missed instructions. I hardly know what osteoporosis is. That's probably why it does not make as much impression on me” (6)
The process of learning to live with osteoporosis was generally found to be highly influenced by the perception of pharmaceutical treatment. The understanding and interpretation of information and medical advice, together with the interpretation of symptoms and scan results were, together with the interviewees’ prior lifestyle, exposed to a deeper reflection. The perceptions of a future DXA scan emerged as an important life event, with expectations and hope for an improved result.
The study adds knowledge to how women, who had not experienced an osteoporosis fracture at the time of diagnosis, learn to live with osteoporosis after being prescribed pharmaceutical treatment. The experiences described a multifaceted process that is highly influenced by the medical treatment and daily life. The interviewees’ daily lives were found to be adapted according to understanding and interpreting of a bigger picture of lifestyle, including bodily “signals” such as past and current symptoms, pain, side effects (or what were perceived as being side effects) as well as the scan results. Moreover, accepting and understanding of the diagnosis was found to be dependent on the adaptation of daily life, and vice versa.
Medical aspects such as having to take medication and side effects have an important role in life with osteoporosis and perhaps especially before a known osteoporotic fracture occurs, since the medication is tangible and has to be managed in one way or another. It may be assumed that the reason why most women are continuously focused on side effects during the first year after diagnosis is due to their understanding of benefits of having been diagnosed and understanding of the importance of the pharmaceutical fracture preventative therapy in decreasing the risk of osteoporotic fractures. Our findings on this central issue contribute to the findings of other studies dealing with treatment-requiring osteoporosis, the initiation of pharmaceutical treatment as well as persisting and complying with anti-osteoporotic therapy [8, 21, 29, 44, 52–54]. Yu et al. specifically investigated reasons for not initiating osteoporosis therapy . They found that 37.6% of 117 survey responders did not initiate recommended osteoporosis medication due to concerns over side effects in 77.3% of the cases. These findings may be seen as consistent with findings in the current study.
The current findings of accepting and understanding the diagnosis are in accordance with studies by Kralik et al. [55, 56] who explored women’s narratives of “being” diagnosed with a long-term illness  and the process of “moving on” when living with a chronic illness or condition . The studies reported that many women experienced receiving the medical diagnosis of their long-term illness as a memorable event in their lives; the experience of getting a diagnostic label was comprehensive and should not be underestimated . Additionally, it was reported that “moving on” with a chronic illness or a condition is a complex process of learning, finding meaning and the redefining of self - a unique journey for each person depending upon their particular situation and context . This was in line with what the women in our study described when reflecting on their lifestyle and trying to understand why they have developed osteoporosis, and how to live their daily lives with this chronic disease. This process may not be specific to osteoporosis, and healthcare professionals treating osteoporosis patients may benefit and learn from studies on other chronic diseases
Similarities may be drawn to the grounded theory study of “healthy risk awareness” , which develops through an emotional cognitive process of acceptance. Being motivated to act in a preventative way was found to impact upon acceptance, which underwent a development through the fear of having fragile bones . Descriptions of fear in the current study were primarily elaborated through concerns related to the medical treatment, side effects and making the right choice, but also concerns regarding possible fractures . These worries were addressed by developing strategies and making adjustments in everyday life. This may be understood as being generated by fear being used to develop “healthy risk awareness” as found in the study by Hjalmarson et al. Developing strategies by taking control has been found to be a way of addressing a negative outcome such as having fractures . Moreover, it was found that strategies have been developed when patients accepted their need for treatment . In the current study, acceptance appeared to be mediated by the perception of the medical treatment. The women were confused by differing information and medical advice from across various sources. They sought to understand the information and interpret their symptoms, side effects and the results of their scan within a bigger picture of daily life with osteoporosis. Significant parts of this understanding and interpretation of the accepting process were related to the decisions regarding taking or discontinuing the medication. The individual perception appears to be an important factor, which should be highlighted when dealing with osteoporotic fracture prevention. One of the most pronounced challenges is to uncover factors which may increase adherence to anti-osteoporotic treatment. In a large national register-based study, it was found that 38.7% of the patients stopped treatment within the first year . Although this is of a smaller scale when compared to international findings [21, 22, 24, 25], it is still a problem from a fracture prevention perspective . The decision-making process has been reported in other studies to be an emotional and cognitive learning process ; a sense-making process ; and a process of trial and error to find useful strategies . One common limitation of these and other qualitative studies that investigate the decision-making process regarding medication use of individuals with osteoporosis appears to be the lack of studies with longitudinal design following patients’ experiences over time (no qualitative studies on this matter were found). The multifaceted factors which were found to be related to decision-making in the current study may be the explanation of why it was found to be a matter of an immediate decision for some, while for others, it was a longer process that developed over time. This finding may be supported by the study of challenges regarding transition to a life with chronic illness .
Implications for research and practice
Interventions targeting osteoporotic fracture prevention that encourage collaboration between patients and healthcare professionals may incorporate approaches of shared decision-making or other equivalent approaches for persistence of use enhancement and patient education. Shared decision-making has been found to be the most effective therapeutic option to increase compliance and persistence to medical treatment, together with fostering greater patient satisfaction and improving the healthcare processes and outcomes for patients . It may, however, be difficult to implement this model, as healthcare professionals may find it hard to take a health-(and an individual) oriented stance and focus on the particular patient’s reaction to the illness in daily life, as it is different from the disease-oriented perspective . Despite potential difficulties, the current study highlights the importance of making room for patients’ individual narratives to strengthen their empowerment. The stories told by patients may naturally find their place as a part of the nursing consultation in the outpatient clinic. A participant-oriented direction requires innovation among healthcare professionals.
Further research is needed. We therefore suggest that further intervention studies comparing current practice to more individualized plans for decision-making adapting to individuals’ need for access to professional advice (such as nursing consultations, telephone hotline or telemedicine [57–59]) may be beneficial when targeting osteoporotic fracture prevention and learning to live with osteoporosis.
Other perspectives, based on the current study results, may provide the opportunity of developing targeted register-based studies. The current study suggests that there is a need for more targeted surveys of patients and healthcare professionals examining their attitude and assessments of information of the treatment, the condition, socio-demographic and health-related factors etc.
Strengths and limitations of the study
The reporting of this qualitative study has sought to meet the recommendations of The Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups (Additional file 2) . This instrument is recommended by BioMed Central. The study comprised of 42 interviews involving 15 participants. This number may be seen as a strength of the study. Additionally, the longitudinal design is considered to provide a thorough exploration of the research question . Since the survey only included women over the age of 65 who voluntarily participated in the study, it is possible to assume, for instance, that younger woman or those who chose not to participate would have brought a different perspective to the results.
Five interviews were conducted by telephone - this was chosen at the convenience of the participants to ensure participation. Telephone interviews can be an effective method of data collection when the interviewer is aware of the challenges involved . When conducting telephone interviews the ability to observe non-verbal communication is missing; instead, however, the tone of the voice can be taken into consideration to conjure a picture of the individual . Based on the previous interactions, we did not get the impression that the interviews by telephone affected the data.
The interviews in this study allowed for open, nuanced descriptions of various aspects of women’s lives after the diagnosis when medical treatment was prescribed. The appearance of the phenomenon “life with osteoporosis” was enabled.
No qualitative study is without the “touch” or influence of the investigation itself or the researcher as an “interacting” individual. When conducting qualitative research, it is crucial to reflect upon possibilities of how the researcher affects the process or whether such an effect can be prevented, during data collection, analysis and interpretation . During interviews, the first author sought to be aware of own preconceptions, not posing leading questions but instead giving the women the opportunity to tell their story and time to pause during its narration, after which the women were encouraged to elaborate upon something they had mentioned with the purpose of clarifying the meaning attached to the individual experience.
Analysis and interpretation were discussed with fellow researchers (CAH: female, AB: male, HK: female and BDP: female) during all three levels of the interpretation to enhance trustworthiness. Involvement of multiple researchers is recommended when conducting qualitative research, as this might strengthen the design of a study. During the analysis process and interpretation multiple researchers may supplement and contest each other’s statements which may enrich and qualify the analysis [49, 63].
Women’s experiences of living with osteoporosis the first year after diagnosis were characterized by a complex process of learning to live with their new life circumstances. This process was found to be highly influenced by finding strategies that encompass taking the medication, side effects or concerns about side effects, the acceptance and interpretation of scan results, symptoms and the diagnosis, as well as decision-making. There is a need for communication tailored to individual needs, since the uncertainty of living with the new life circumstances may be overwhelming and may lead to inappropriate decisions which could affect pharmaceutical treatment. Improved individualized support for women in the process of learning to live with osteoporosis may be improved through using a health-oriented stance. More research is needed from the perspective of both health promotion and prevention.
Bone mineral density
Dual-energy X-ray absorptiometry
My greatest appreciation and thanks to department of Neuroanesthesiology, Rigshospitalet - Glostrup for support and allocated time during data analysis and preparation of the article.
Thank you, Rebeka Sujic for reading the manuscript and give your feedback.
The study was conducted in relation to dept. of Medicine C and dept. of Medicine F at Copenhagen University Hospital, Gentofte.
Allocated funds from University of Southern Denmark, Gentofte University Hospital, Capital Region - Research Foundation for Health Research, Aase and Ejnar Danielsens Foundation, The Osteoporosis Society Denmark, Cabinetmaker Sophus Jacobsen and wife Astrid Jacobsens Fond.
Availability of data and materials
The datasets generated during and/or analyzed during the current study are not publicly available due to the policy of the Danish Data Protection Agency requesting anonymization and annihilation of personally identifiable data, audio files and full transcriptions. Anonymised files of results are available from the corresponding author on reasonable request.
CAH conceived and coordinated the study, carried out the interviews, and participated in the analysis and drafted the manuscript. BA participated in the design of the study, coordination and appropriate clinical contacts. HK participated in the design of the study and in the analysis. BDP participated in the design of the study and in the analysis. All authors read and approved the final manuscript.
CAH: The author declares that she has no competing interest. BA: has served as an investigator in clinical trials and on advisory boards and/or speakers panels for pharmaceutical companies that produce osteoporosis drugs. Clinical trials: Amgen, NPS Pharmaceuticals. Advisory boards: Amgen, Takeda-Nycomed. Speakers panels: Amgen, Nycomed, Eli Lilly, Merck. HK: The author declares that she has no competing interest. BDP: The author declares that she has no competing interest.
Consent for publication
The women gave informed consent to participate in the study, and to publish the study results.
Ethics approval and consent to participate
The study was approved by the Danish Data Protection Agency (J.no. 2012–41–0875) and the National Committee on Health Research Ethics (J.no. H-C-FSP-2011_01). Preliminary, to etch interview the women were informed of the purpose of the study and informed consent was obtained.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Cadarette SM, Burden AM. Measuring and improving adherence to osteoporosis pharmacotherapy. Curr Opin Rheumatol. 2010;22(4):397–403. doi:10.1097/BOR.0b013e32833ac7fe.View ArticlePubMedPubMed CentralGoogle Scholar
- Genant HK, Cooper C, Poor G, Reid I, Ehrlich G, Kanis J, et al. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int. 1999;10(4):259–64. doi:10.1007/s001980050224.View ArticlePubMedGoogle Scholar
- Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013;24(1):23–57. doi:10.1007/s00198-012-2074-y.View ArticlePubMedGoogle Scholar
- Reginster JY, Burlet N. Osteoporosis: a still increasing prevalence. Bone. 2006;38(2 Suppl 1):S4–9. doi:10.1016/j.bone.2005.11.024.View ArticlePubMedGoogle Scholar
- Vestergaard P, Rejnmark L, Mosekilde L. Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int. 2005;16(2):134–41. doi:10.1007/s00198-004-1680-8.View ArticlePubMedGoogle Scholar
- Cooper C, Harvey NC. Osteoporosis risk assessment. BMJ. 2012;344:e4191. doi:10.1136/bmj.e4191.View ArticlePubMedGoogle Scholar
- Cockerill W, Lunt M, Silman AJ, Cooper C, Lips P, Bhalla AK, et al. Health-related quality of life and radiographic vertebral fracture. Osteoporos Int. 2004;15(2):113–9. doi:10.1007/s00198-003-1547-4.View ArticlePubMedGoogle Scholar
- Weston JM, Norris EV, Clark EM. The invisible disease: making sense of an osteoporosis diagnosis in older age. Qual Health Res. 2011;21(12):1692–704. doi:10.1177/1049732311416825.View ArticlePubMedPubMed CentralGoogle Scholar
- Hakestad KA, Nordsletten L, Torstveit MK, Risberg MA. Postmenopausal women with osteopenia and a healed wrist fracture have reduced physical function and quality of life compared to a matched, healthy control group with no fracture. BMC Womens Health. 2014;14:92. doi:10.1186/1472-6874-14-92.View ArticlePubMedPubMed CentralGoogle Scholar
- Abrahamsen B, van ST, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. 2009;20(10):1633–50. doi:10.1007/s00198-009-0920-3.View ArticlePubMedGoogle Scholar
- Cooper C, Atkinson EJ, Jacobsen SJ, O’Fallon WM, Melton III LJ. Population-based study of survival after osteoporotic fractures. Am J Epidemiol. 1993;137(9):1001–5. PMID: 8317445.View ArticlePubMedGoogle Scholar
- Cooper C, Rizzoli R, Reginster JY. The International Osteoporosis Foundation: history, objectives and achievements. Osteoporos Int. 2009;20 Suppl 3:S241–2. doi:10.1007/s00198-008-0700-5.View ArticlePubMedGoogle Scholar
- Kanis JA, Melton III LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137–41. doi:10.1002/jbmr.5650090802.View ArticlePubMedGoogle Scholar
- World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. 1994;843:1–129. http://apps.who.int/iris/bitstream/10665/39142/1/WHO_TRS_843_eng.pdf.Google Scholar
- World Health Organization. Prevention and Management of Osteoporosis. Report of WHO Scientific Group. http://whqlibdoc.who.int/trs/who_trs_921.pdf. Accessed 8 Oct 2008.
- Abrahamsen B, Vestergaard P. Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997–2006. Osteoporos Int. 2010;21(3):373–80. doi:10.1007/s00198-009-0957-3.View ArticlePubMedGoogle Scholar
- Kanis JA, Glüer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int. 2000;11(3):192–202. doi:10.1007/s001980050281.View ArticlePubMedGoogle Scholar
- Statistics Denmark. https://www.statistikbanken.dk/statbank5a/default.asp?w=1920. Accessed 8 Oct 2008.
- Olsen KR, Hansen C, Abrahamsen B. Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs-an analysis using national health databases. Osteoporos Int. 2013;24(10):2639–47. doi:10.1007/s00198-013-2365-y.View ArticlePubMedGoogle Scholar
- Reginster JY, Brandi ML. Fracture prevention in osteoporosis: assessing risks, providing solutions. Osteoporos Int. 2010;21 Suppl 2:S401–2. doi:10.1007/s00198-010-1243-0.View ArticlePubMedGoogle Scholar
- Landfeldt E, Strom O, Robbins S, Borgstrom F. Adherence to treatment of primary osteoporosis and its association to fractures--the Swedish Adherence Register Analysis (SARA). Osteoporos Int. 2012;23(2):433–43. doi:10.1007/s00198-011-1549-6.View ArticlePubMedGoogle Scholar
- Siris ES, Harris ST, Rosen CJ, Barr CE, Arvesen JN, Abbott TA, et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc. 2006;81(8):1013–22. AN 21973041.View ArticlePubMedGoogle Scholar
- Hansen C, Pedersen BD, Konradsen H, Abrahamsen B. Anti-osteoporotic therapy in Denmark-predictors and demographics of poor refill compliance and poor persistence. Osteoporos Int. 2013;24(7):2079–97. doi:10.1007/s00198-012-2221-5.View ArticlePubMedGoogle Scholar
- Devold HM, Furu K, Skurtveit S, Tverdal A, Falch JA, Sogaard AJ. Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway. Pharmacoepidemiol Drug Saf. 2012;21(3):297–304. doi:10.1002/pds.2344.View ArticlePubMedGoogle Scholar
- Wastesson JW, Ringback WG, Parker MG, Johnell K. Educational level and use of osteoporosis drugs in elderly men and women: a Swedish nationwide register-based study. Osteoporos Int. 2013;24(2):433–42. doi:10.1007/s00198-012-1945-6.View ArticlePubMedGoogle Scholar
- Huas D, Debiais F, Blotman F, Cortet B, Mercier F, Rousseaux C, et al. Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment. BMC Womens Health. 2010;10:26. doi:10.1186/1472-6874-10-26.View ArticlePubMedPubMed CentralGoogle Scholar
- Hjalmarson HV, Straudmark M, Klässbo M. Healthy risk awareness motivates fracture prevention behavior: A grounded theory study of women with osteoporosis. Int J Qual Stud Health Well -being. 2007;2:236–45. doi:10.1080/17482620701436939.View ArticleGoogle Scholar
- Lau E, Papaioannou A, Dolovich L, Adachi J, Sawka AM, Burns S, et al. Patients’ adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women. Can Fam Physician. 2008;54(3):394–402. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2278357/pdf/0540394.pdf.PubMedGoogle Scholar
- Nielsen D, Huniche L, Brixen K, Sahota O, Masud T. Handling knowledge on osteoporosis - a qualitative study. Scand J Caring Sci. 2012;27:0238–9318. doi:10.1111/j.1471-6712.2012.01055.x.Google Scholar
- Reventlow S, Bang H. Brittle bones: ageing or threat of disease exploring women’s cultural models of osteoporosis. Scand J Public Health. 2006;34(3):320–6. doi:10.1080/14034940500327869.View ArticlePubMedGoogle Scholar
- Reventlow SD, Hvas L, Malterud K. Making the invisible body visible. Bone scans, osteoporosis and women’s bodily experiences. Soc Sci Med. 2006;62(11):2720–31. doi:10.1016/j.socscimed.2005.11.009.View ArticlePubMedGoogle Scholar
- Reventlow SD. Perceived risk of osteoporosis: restricted physical activities? Qualitative interview study with women in their sixties. Scand J Prim Health Care. 2007;25(3):160–5. doi:10.1080/02813430701305668.View ArticlePubMedGoogle Scholar
- Roberto KA, Reynolds SG. The meaning of osteoporosis in the lives of rural older women. Health Care Women Int. 2001;22(6):599–611. doi:10.1080/07399330127198.View ArticlePubMedGoogle Scholar
- Mazor M, Velten S, Andrade E, Yood A. Older Women’s Views about Prescription Osteoporosis Medication: A Cross-Sectional, Qualitative Study. Drugs Aging. 2010;27(12):999–1009. doi:10.2165/11584790-000000000-00000.View ArticlePubMedGoogle Scholar
- Wilkins S. Women with osteoporosis: strategies for managing aging and chronic illness. J Women Aging. 2001;13(3):59–77. doi:10.1300/J074v13n03_05.View ArticlePubMedGoogle Scholar
- Wilkins S. Aging, chronic illness and self-concept: a study of women with osteoporosis. J Women Aging. 2001;13(1):73–92. doi:10.1300/J074v13n01_06.View ArticlePubMedGoogle Scholar
- McLeod KM, Johnson CS. A systematic review of osteoporosis health beliefs in adult men and women. J Osteoporos. 2011;2011:197454–65. doi:10.4061/2011/197454.View ArticlePubMedPubMed CentralGoogle Scholar
- Ricoeur P. Interpretation Theory: Discourse and the surplus of meaning. Fort Worth: Christian University Press; 1976. https://www.uni-trier.de/fileadmin/fb1/prof/PHI/003/Bilddateien/Ricoeur_Interpretation_Theory.pdf.Google Scholar
- Lindseth A, Norberg A. A phenomenological hermeneutical method for researching lived experience. Scand J Caring Sci. 2004;18(2):145–53. doi:10.1111/j.1471-6712.2004.00258.x.View ArticlePubMedGoogle Scholar
- Pedersen BD. Sygeplejepraksis. Sporg & erkendelse [Nursing practice Language and cognition]. 3 2005 ed. Denmark: PhD thesis, The Faculty of Health Science, University of Aarhus; 1999.
- Hermansen M, Rendorff JD. En Hermenutisk Brobygger - tekster af Ricoeur [A Hermenutic Bridging – texts by Ricoeur]. Århus: Forlaget Klim; 2002.Google Scholar
- Pahuus M. Hermenutik [Hermeneutic]. In: Collin F, Køppe S, editors. Humanistisk Videnskabsteori [Hermeneutic science]. DR Multimedie. 2001. p. 109–37.Google Scholar
- Saldaña J. Longitudinal Qualitatve Research: analyzing changes through time. Walnut Creek: AltaMira Press; A Division of Rowman & Littlefield Publishers, Inc. Walnut Creek; 2003.
- Hansen C, Konradsen H, Abrahamsen B, Pedersen BD. Women’s experiences of their osteoporosis diagnosis at the time of diagnosis and six month later: A phenomenological hermeneutic study. Int J Quaitative Stud Health Well-being. 2014;9:22438. doi:10.3402/qhw.v9.22438.View ArticleGoogle Scholar
- Hansen C. Life with osteoporosis - a cohort and qualitative study. Serial no 2014 ed. Denmark: PhD thesis, Faculty of Health Sciences, University of Southern Denmark; 2014. http://wp.dkms.dk/wp-content/uploads/2013/04/Carrinna_Hansen_phd_afhandling_samlet.pdf.
- Lindberg MJ, Andersen SE, Christensen HR, Kampmann JP. Compliance to drug prescriptions. Ugeskr Laeger. 2008;170(22):1912–6. PMID:18513472.PubMedGoogle Scholar
- World Health Organization. Adherence to Long-Term Therapies, Evidence for Action. http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf. Accessed 8 Oct 2008.
- Holloway I. Vulnerable story telling: narrative research in nursing. J Res Nurs. 2007;12(6):703–11. doi:10.1177/1744987107084669.View ArticleGoogle Scholar
- Kvale S, Brinkmann S. Interviews - Learning the Craft of Qualitative Research Interviewing. 2nd ed. Thousand Oaks: SAGE Publications, Inc.; 2009.Google Scholar
- World Medical Association. World Medical Association Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013;310(20):2191–4. doi:10.1001/jama.2013.281053.View ArticleGoogle Scholar
- Herzog H. On Home Turf: Interview Location and Its Social Meaning. Qual Sociol. 2005;28(1):25–47. doi:10.1007/s11133-005-2629-8.View ArticleGoogle Scholar
- Kothawala P, Badamgarav E, Ryu S, Miller RM, Halbert RJ. Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc. 2007;82(12):1493–501. AN 27828553.View ArticlePubMedGoogle Scholar
- Roerholt C, Eiken P, Abrahamsen B. Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence. Osteoporos Int. 2009;20(2):299–307. doi:10.1007/s00198-008-0651-x.View ArticlePubMedGoogle Scholar
- Yu J, Brenneman SK, Sazonov V, Modi A. Reasons for not initiating osteoporosis therapy among a managed care population. Patient Prefer Adher. 2015;9:821–30. doi:10.2147/PPA.S81963.Google Scholar
- Kralik D, Brown M, Koch T. Women’s experiences of ‘being diagnosed’ with a long-term illness. J Adv Nurs. 2001;33(5):594–602. http://dx.doi.org.ep.fjernadgang.kb.dk/10.1046/j.1365-2648.2001.01704.x.View ArticlePubMedGoogle Scholar
- Kralik D, Telford K, Campling F, Crouch P, Koch T, Price K. ‘Moving on’: the transition to living well with chronic illness. Aust J Holist Nurs. 2005;12(2):13–22. PMID: 19175260 NLM UID: 100886426.PubMedGoogle Scholar
- Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag. 2005;1(3):189–99. PMID:18360559 PMCID: PMC1661624.PubMedPubMed CentralGoogle Scholar
- Zoffmann V, Harder I, Kirkevold M. A person-centered communication and reflection model: sharing decision-making in chronic care. Qual Health Res. 2008;18(5):670–85. PMID: 18223158 NLM UID: 9202144.View ArticlePubMedGoogle Scholar
- Dickson L, Cameron C, Hawker G, Ratansi A, Radziunas I, et al. Development of a multidisciplinary osteoporosis telehealth program. Telemed J E Health. 2008;14(5):473–8. doi:10.1089/tmj.2007.0079.View ArticlePubMedGoogle Scholar
- Musselwhite K, Cuff L, McGregor L, King KM. The telephone interview is an effective method of data collection in clinical nursing research: a discussion paper. Int J Nurs Stud. 2007;44(6):1064–70. doi:10.1016/j.ijnurstu.2006.05.014.View ArticlePubMedGoogle Scholar
- Angel S. Grasping the experience of the other from an interview: Self-transposition in use. Int J Qualitative Stud Health Well-being. 2013;8:20634. PMID:23972102 PMCID:PMC3752432.View ArticleGoogle Scholar
- Malterud K. Qualitative research: standards, challenges, and guidelines. Lancet. 2001;358(9280):483–8. doi:10.1016/S0140-6736(01)05627-6.View ArticlePubMedGoogle Scholar
- Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care. 2007;19(6):349–357.